Archives
-
PF-573228 Workflows for FAK Signaling
2026-09-28
Use PF-573228 to test whether FAK activity connects matrix mechanics to cell signaling and behavior, with target-engagement measurements paired to functional assays. This practical guide adapts a stiffness-driven dentinogenesis study into a controlled workflow while distinguishing its findings from separate cancer and endothelial applications.
-
Reading Vascular Remodeling Through EdU
2026-09-27
EdU-based S-phase measurements can help translational researchers connect molecular interventions to vascular cell behavior. This article shows how to use EdU Imaging Kits (Cy5) as one component of a rigorous pulmonary hypertension research strategy, while distinguishing DNA synthesis from broader claims about proliferation or therapeutic efficacy.
-
CERES–XIAN Links dsRNA to Plant Mitochondrial ROS
2026-09-26
The study identifies AtCERES and its partner AtXIAN as components of plant double-stranded RNA-triggered immunity, connecting dsRNA perception to mitochondrial reactive oxygen species (mROS). Its findings distinguish this response from RBOHD-dependent ROS production and suggest mROS is required for the measured immune outputs, while leaving the initial dsRNA recognition mechanism unresolved.
-
WST-8 Cell Viability Assays for Hydrogel Research
2026-09-25
Use WST-8 to compare how wound-repair hydrogel formulations affect cellular metabolic activity, while controlling for material-related optical and redox interference. A practical workflow connects viability screening to the multifunctional MnO₂–calcium hydrogel findings without treating a colorimetric readout as proof of tissue repair.
-
Oleic Acid (C18:1(9Z)) in Lipid Models
2026-09-25
Use Oleic Acid to build and tune fatty-acid loading models, then connect lipid accumulation to cholesterol synthesis, efflux, and stress signaling. A recent liver-injury study offers a useful assay-design framework—but its findings on a botanical extract should not be mistaken for direct evidence of an Oleic Acid treatment effect.
-
MK-5108 (VX-689) in Aurora-A Assays
2026-09-24
Use MK-5108 (VX-689) to test whether Aurora-A activity contributes to mitotic progression and tumor-cell growth, with retinoblastoma providing a clinically relevant hypothesis. A practical workflow pairs a concentration–response assay with cell-cycle readouts and AURKA-focused controls—without mistaking biochemical potency for a validated cellular dose.
-
AAPH Workflows for Protein Oxidation and Antioxidant Testing
2026-09-24
Use AAPH to build a controllable peroxyl-radical challenge for protein functionality, antioxidant screening, and oxidative-injury assays. A hazelnut-protein study highlights why dose matters: 1.0 mmol/L AAPH produced the study’s highest reported water-holding and emulsion metrics, but that result is a benchmark—not a universal optimum.
-
CFDA-SE: Proliferation Tracking Meets CD38 Surfaceomics
2026-09-23
CFDA-SE provides a division-sensitive fluorescence record for viable cells, making it useful for proliferation assays and migration experiments where cell division could confound endpoint counts. Paired thoughtfully with nanobody-TurboID surfaceome analysis, it adds a complementary functional readout—not evidence that a neighboring protein causes a change in proliferation or migration.
-
Ouabain Workflows for Na+/K+-ATPase Research
2026-09-23
Ouabain enables controlled interrogation of sodium-potassium pump activity, calcium handling, and cardiotonic steroid physiology across cell and animal models. This practical guide combines concentration planning, time-resolved response measurements, and troubleshooting strategies for cardiovascular research and ion-transport assays.
-
SMYD2 Inhibition Protects Against Renal Fibrosis
2026-09-22
The reference study identifies SMYD2 as a pharmacologically tractable regulator of cisplatin-induced chronic kidney disease, renal fibrosis, and inflammation. Using AZ505 and LLY507 in an experimental CKD model, the authors connect SMYD2 inhibition with reduced epithelial-to-mesenchymal transition, extracellular matrix-associated pathology, inflammatory cytokines, and Smad3/STAT3 signaling.
-
Bafilomycin C1 in High-Content Cell Assays
2026-09-22
Bafilomycin C1 is a vacuolar H+-ATPases inhibitor that links lysosomal acidification to interpretable cellular phenotypes. This guide shows how to integrate it into high-content autophagy assays, apoptosis research, and deep-learning-enabled screening without confusing mechanism with nonspecific toxicity.
-
MitMAB: A Causal Probe for EV Uptake
2026-09-21
Polarity-aware intestinal organoids are redefining how researchers study milk-derived extracellular vesicle uptake. This thought-leadership guide explains how MitMAB, a dynamin GTPase activity inhibitor, can strengthen causal testing while preserving the distinction between pathway evidence, assay artifacts, and translational promise.
-
Biodentine Rejuvenates Aging Dental Pulp Stem Cells
2026-09-21
The reference study identifies Biodentine as a bioactive material that can restore proliferation and reduce senescence-associated features in human dental pulp stem cells from older donors. Its use of XAV939 links these effects to Wnt/β-catenin signaling, providing a mechanistic rationale for studying Biodentine in age-sensitive vital pulp therapy.
-
JIB-04 Targets Colorectal Cancer Stem Cells
2026-09-20
The reference study identified JIB-04 as a small-molecule epigenetic inhibitor that preferentially suppresses colorectal cancer stem-cell phenotypes. Its data connect histone demethylase inhibition with reduced Wnt/β-catenin activity, impaired tumor-sphere behavior, and lower tumorigenicity, while also highlighting important limits in assigning a single molecular target.
-
Neuromedin S (rat): Practical Assay Guide
2026-09-19
Neuromedin S (rat), SKU B5466, provides a defined endogenous neuromedin U receptor agonist for controlled rat-oriented GPCR/G protein signaling workflows. This guide addresses preparation, assay controls, storage, and interpretation boundaries; it does not establish therapeutic use, diagnostic validity, cross-species activity, or assay-specific potency.